Adverse effects of TNF inhibitor in a patient with DiGeorge syndrome and juvenile idiopathic arthritis

Ann Allergy Asthma Immunol. 2020 Feb;124(2):207-208. doi: 10.1016/j.anai.2019.11.006. Epub 2019 Nov 14.

Authors

Mario Sestan¹, Nastasia Kifer¹, Marijan Frkovic¹, Ana-Marija Laskarin², Marija Jelusic³

Affiliations

¹ Department of Paediatrics, University Hospital Centre Zagreb, University of Zagreb School of Medicine, Zagreb, Croatia.
² Study of Dental Medicine, Medical Faculty, University of Rijeka, Rijeka, Croatia.
³ Department of Paediatrics, University Hospital Centre Zagreb, University of Zagreb School of Medicine, Zagreb, Croatia. Electronic address: marija.jelusic@mef.hr.

PMID: 31734327
DOI: 10.1016/j.anai.2019.11.006

No abstract available

Publication types

Case Reports
Letter

MeSH terms

Arthritis, Juvenile / complications*
Arthritis, Juvenile / diagnosis*
Arthritis, Juvenile / drug therapy
Arthritis, Juvenile / etiology
Biomarkers
DiGeorge Syndrome / complications*
DiGeorge Syndrome / diagnosis
DiGeorge Syndrome / genetics
Humans
Immunoglobulin G / blood
Immunoglobulin G / immunology
Immunoglobulin M / blood
Immunoglobulin M / immunology
Immunoglobulins, Intravenous / therapeutic use
Tumor Necrosis Factor Inhibitors / adverse effects*
Tumor Necrosis Factor Inhibitors / therapeutic use
Young Adult

Substances

Biomarkers
Immunoglobulin G
Immunoglobulin M
Immunoglobulins, Intravenous
Tumor Necrosis Factor Inhibitors